Age ≥ 18;
Patients diagnosed with HF and SCH according to any of the diagnostic criteria are eligible to be included;
There are no restrictions on race, nationality, gender, or age;
Before inclusion in the study, patients were not treated with thyroxine;
Patients with cardiac resynchronization therapy or coronary artery bypass surgery, or with severe non-cardiovascular events were excluded.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.